Fig. 8From: FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinomaThe TIDE scores in the low expression of FANCD2 and high expression of FANCD2. TIDE, tumor immune dysfunction and exclusionBack to article page